Management of 3 Cases of Pheochromocytoma during the COVID-19 Pandemic in New York City: Lessons Learned

Emily A. Japp, Amanda Leiter, Effie A. Tsomos, Sarah A. Reda, Alice C. Levine

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

The COVID-19 crisis placed a pause on surgical management of nonemergency cases of pheochromocytoma, and it was essential for endocrinologists to provide both resourceful and safe care. At the Mount Sinai Hospital in New York City during the peak of the pandemic, we encountered 3 patients with pheochromocytoma and mild symptoms that were medically managed for a prolonged period of time (7-18 weeks) prior to adrenalectomy. Patients were monitored biweekly via telemedicine, and antihypertensive medications were adjusted according to signs, symptoms, and adrenergic profiles. These cases demonstrate that prolonged medical management prior to surgery is feasible and effective in pheochromocytoma patients with mild symptoms and well-controlled blood pressures.

Original languageEnglish
Article numberbvaa198
JournalJournal of the Endocrine Society
Volume5
Issue number2
DOIs
StatePublished - 1 Feb 2021

Keywords

  • COVID-19
  • adrenal mass
  • pheochromocytoma

Fingerprint

Dive into the research topics of 'Management of 3 Cases of Pheochromocytoma during the COVID-19 Pandemic in New York City: Lessons Learned'. Together they form a unique fingerprint.

Cite this